(PDMP)
16.754
Goals: To enhance the capacity of regulatory and law enforcement agencies to collect and analyze controlled substance prescription data through a centralized database administered by an authorized state agency and federally recognized Indian tribal governments. Objectives: •Implement and enhance prescription drug monitoring programs. • Develop and enhance public safety, behavioral health, and public health information sharing partnerships that leverage key public health and public safety data sets (e.g., identified PDMP data, naloxone administrations, fatal and non-fatal overdose data, drug arrests) and develop interventions based on this information. Performance Measure 1: Percent of grantees with a registered prescriber rate above 65% in their state PDMPs. Performance Measure 2: Did you develop any data-sharing agreements during the reporting period? Performance Measure 3: Did you identify any hotspots as a result of any analyses done during the reporting period?
This chart shows obligations for the program by fiscal year. All data for this chart was provided by the
administering agency and sourced from SAM.gov, USASpending.gov, and Treasury.gov.
For more information on each of these data sources, please see the
About the data page.
• Currently, 49 states, the District of Columbia, and the U.S. territory of Guam have an operational PDMP. St. Louis County, Missouri’s PDMP is also live.
• Missouri has pending state legislation to authorize a PDMP.
• Interstate data sharing has expanded significantly in the last two years. Forty states are sharing with at least one other state; nine states are in the process of initiating interstate data sharing; Guam, Hawaii and Oregon are not presently sharing data outside of the state.
• 33 states now require prescribers to query the database for all controlled substance prescriptions or under certain circumstances as a result of BJA’s training and technical assistance program in the last three years.
• Currently, 49 states, the District of Columbia, and the U.S. territory of Guam have an operational PDMP. 80 percent of Missouri’s counties are also actively contributing data to the PDMP.
• Interstate data sharing has expanded significantly in the last two years. All but three states are engaged with interstate data sharing on some level.
• All but 8 states and territories require that prescribers or dispensers query the database for controlled substance prescriptions or under certain circumstances.
• PDMPs are operational in every state, Guam, Puerto Rico, and the District of Columbia, although Missouri is not operational statewide.
• Forty-seven states are currently able to exchange prescription data with each other. In some instances, data sharing may be limited to a couple of neighboring states. In other instances, data sharing may span states within a specific region.
• As of October 2018, 19 states have mandatory use requirements for prescribers and dispensers in certain circumstances; 24 states and one territory have mandatory use requirements for prescribers only in certain circumstances; and seven states, the District of Columbia and no territories have no mandatory use requirement.
BJA FY 21 Harold Rogers Prescription Drug Monitoring Program (PDMP) awarded 16 grants totaling $24, 976,549
Please see the following weblink for results of 2023 assessment:
PDMP Policies and Capabilities 2023 Assessment Results_final_20240108.pdf
PDMPs continue to evolve into one of the most efficient and effective tools in the battle to reduce prescription drug misuse and diversion. PDMPs are continuously improving and being more responsive to stakeholders with more relevant, timely, and accurate information. PDMPs are widely recognized as an important tool in addressing the drug abuse epidemic. PDMP systems maintain a variety of information. The data collected by all the PDMPs is very similar across the country, with some PDMPs having additional information. Every PDMP receives data on a controlled substance prescription. While there is some variation, most PDMPs track schedules two through five. Some PDMPs are now tracking information from all prescriptions, not just controlled substance medications. In addition, most PDMPs have the authority to track drugs of concern. Drugs of concern are medications that are not controlled substances, but the state, territory, district, or commonwealth has determined that these medications are being misused or abused. Designating a drug of concern is typically accomplished through the promulgation of administrative rules. Examples include gabapentin or butalbital. Additional data fields that may be tracked include the source of payment for the prescription; cash, commercial insurance, Medicare, Medicaid. Some PDMPs are collecting the international classification of diseases, or ICD 10 codes. It’s code to identify a disease or diagnosis.
In addition to being a tool for health care providers, PDMPs are also used as a resource for law enforcement when investigating prescription drug-related crimes. Depending on the PDMP, law enforcement must either have an official document such as a court order, search warrant, or subpoena or show proof of an active investigation or probable cause. Although the prescription data alone has proven to be extremely useful for health care providers, many PDMPs perform different data types of analytics to help summarize and inform the provider about their patient’s prescription history. The PDMP data fields can easily be analyzed based on geographic location, types of medications dispensed, medication combinations, overdose risk, and indicators of suspicious activity. The analytics are graphically displayed on a PDMP report.
Single Audit Applies (2 CFR Part 200 Subpart F):
For additional information on single audit requirements for this program, review the current Compliance Supplement.
OMB is working with the U.S. Government Accountability Office (GAO) and agency offices of inspectors general to include links to relevant oversight reports. This section will be updated once this information is made available.